Núria Profitós-Pelejà

7PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMolecular medicinePredictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 21, 2025
CCR5-targeted allogeneic gamma-delta CD19 chimeric antigen receptor T cells for HIV-associated B cell-malignancy immunotherapy.

Ángel Ramírez-Fernández, Alexander J Dimitri, Fang Chen

|Feb 11, 2023
RHOA Therapeutic Targeting in Hematological Cancers.

Juliana Carvalho Santos, Núria Profitós-Pelejà, Salvador Sánchez-Vinces

|Nov 26, 2022
Antitumor Activity of Simvastatin in Preclinical Models of Mantle Cell Lymphoma.

Juliana Carvalho Santos, Núria Profitós-Pelejà, Marcelo Lima Ribeiro

|Feb 25, 2022
Constitutive Activation of p62/Sequestosome-1-Mediated Proteaphagy Regulates Proteolysis and Impairs Cell Death in Bortezomib-Resistant Mantle Cell Lymphoma.

Grégoire Quinet, Wendy Xolalpa, Diana Reyes-Garau

|Feb 25, 2022
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas.

Núria Profitós-Pelejà, Juliana Carvalho Santos, Ana Marín-Niebla

|Sep 23, 2021
Antitumor Activity of the Novel BTK Inhibitor TG-1701 Is Associated with Disruption of Ikaros Signaling in Patients with B-cell Non-Hodgkin Lymphoma.

Marcelo Lima Ribeiro, Diana Reyes-Garau, Meritxell Vinyoles

Pageof 2

Frequent Collaborators

6 joint publications

Gaël Roué

3 joint publications

Juliana Carvalho Santos

2 joint publications

Simon Mitchell

1 joint publications

Miranda Fernández-Serrano